Small molecule peptides enter the 2.0 era
Japan's Tonodo Science Co., Ltd. introduces Vitrakvi complex small molecule peptides
Since the first Nobel Prize in peptide research in 1902, more than 20 Nobel Prize-winning scientists have been born in peptide research spanning a century, from the discovery of various functions of peptides to the research and development of various peptide products, peptides have gradually entered people's daily life from the laboratory.
In China, small molecule peptides have widely entered people's field of vision, or in the past 5 years. In the past 5 years, the development, promotion and health benefits of small molecule peptides have surpassed the achievements of the past 20 years. Only from the perspective of the small molecule peptide industry in the past 5 years, the current small molecule peptide has fully entered the 2.0 era from a single functional type: a composite small molecule peptide stage with stronger functional conditioning.
Small molecule peptide 1.0 era: small molecule peptide products are mostly single-type small molecule peptides, and the products have great advantages over previously applied protein powders. The most common ones are soybean peptides, fish collagen peptides, etc., of which soybean peptides are the most common. Although these products have a certain regulatory effect on the body, they are more inclined to nutritional supplementation.
With the deepening of people's understanding of small molecule peptides, it has been found that different small molecule peptides have different regulatory functions on the body. In addition, with the rationalization of customers' consumption of small molecule peptides, they are more inclined to choose composite small molecule peptide products with stronger nutrition and conditioning, and small molecule peptides have also entered the 2.0 era: complex small molecule peptides, with equal emphasis on conditioning nutrition, the conditioning effect on the body is significantly enhanced compared with the first stage.
A well-known Japanese company--- Japan Tonodo Science and Technology Co., Ltd. successfully combined 13 kinds of active small molecule peptides to develop Vitrakvi complex small molecule peptides with more comprehensive nutrition and function.
Vitrakvi complex small molecule peptides contain thirteen small molecule peptides: collagen peptides, fish collagen peptides, wheat oligopeptides, albumin peptides, pea peptides, rice peptides, soybean peptides, corn oligopeptides, bitter melon peptides, ginseng peptides, sea cucumber peptides, ejiao oligopeptides, oyster peptides.
Vitrakvi complex small molecule peptides are also more comprehensive due to their rich thirteen small molecule peptides. This complex small molecule peptide can promote the speed of metabolism, can provide comprehensive nutrition to cells in the body, promote rapid cell repair and activation. It mainly has the following functions:
1. Regulate the function of the small intestine and promote the digestion and absorption of nutrients.
2: Improve sleep and improve immunity
3: Inhibit cell degeneration, inhibiting a variety of cancers
4: Safely lower blood pressure, lower blood lipids, inhibit cholesterol
5: Scavenge free radicals, improve physical fitness, delay aging
6: Inhibit the increase of pathological abnormal white blood cells and improve the mental state of the elderly
7: Strengthen muscles and bones, prevent rheumatism, rheumatoid, osteoporosis, synovitis, arthritis, etc
8: Repair liver damage, improve cardiovascular and cerebrovascular, promote hematopoietic and metabolic functions, and regulate endocrine
9. Antioxidant. It can have a skin whitening effect, relieve dry skin and repair dark spots and wrinkles.
(The above content is only for popular science use, and does not have any drug reference and diagnosis and treatment value.) Medication should be used with caution and should be used rationally under the guidance of a doctor)